← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 25, 2020Last known activity
Mar 7, 2023
Timeline
2010s
- Jun 1, 2019
Vaxxinity, Inc.— Founded
Drugs by trial phase (5 distinct, 7 trials)
Phase 3 (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (9)
- NCT05762276Study directorPhase 1Mar 7, 2023
- NCT05762276Lead sponsorPhase 1Mar 7, 2023
- NCT05477095Lead sponsorPhase 1Jul 6, 2022
- NCT05477095Study directorPhase 1Jul 6, 2022
- NCT05293665Lead sponsorPhase 3Mar 16, 2022
- NCT04967742CollaboratorPhase 1Aug 5, 2021
- NCT04683224Lead sponsorPhase 2/Phase 3Feb 1, 2021
- NCT04773067CollaboratorPhase 2Jan 30, 2021
- NCT04545749CollaboratorPhase 1Sep 25, 2020
Details
- Founded
- Dallas, TX, US Jun 1, 2019
- Last known activity
- Mar 7, 2023